Seuraa
Ozgur Kutuk
Ozgur Kutuk
Sabanci University
Vahvistettu sähköpostiosoite verkkotunnuksessa sabanciuniv.edu
Nimike
Viittaukset
Viittaukset
Vuosi
Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis
O Kutuk, H Basaga
Trends in molecular medicine 9 (12), 549-557, 2003
2052003
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737
O Kutuk, A Letai
Cancer research 68 (19), 7985-7994, 2008
1702008
Phytoestrogens in functional foods
F Yildiz
CRC Press, 2019
1662019
Regulation of Bcl-2 family proteins by posttranslational modifications
A Letai, O Kutuk
Current molecular medicine 8 (2), 102-118, 2008
1432008
Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis
O Kutuk, H Basaga
Apoptosis 11, 1661-1675, 2006
1222006
Protein kinases as drug targets in cancer
MA Arslan, O Kutuk, H Basaga
Current cancer drug targets 6 (7), 623-634, 2006
1102006
High depression symptoms and burnout levels among parents of children with autism spectrum disorders: A multi-center, cross-sectional, case–control study
MÖ Kütük, AE Tufan, F Kılıçaslan, G Güler, F Çelik, E Altıntaş, C Gökçen, ...
Journal of autism and developmental disorders, 1-14, 2021
1072021
Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells
O Kutuk, A Letai
Cell Death & Differentiation 17 (10), 1624-1635, 2010
1032010
Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance
J Kale, O Kutuk, GC Brito, TS Andrews, B Leber, A Letai, DW Andrews
EMBO reports 19 (9), e45235, 2018
922018
Aspirin inhibits TNFα-and IL-1-induced NF-κB activation and sensitizes HeLa cells to apoptosis
O Kutuk, H Basaga
Cytokine 25 (5), 229-237, 2004
792004
Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer
Ö Saatci, S Borgoni, Ö Akbulut, S Durmuş, U Raza, E Eyüpoğlu, C Alkan, ...
Oncogene 37 (17), 2251-2269, 2018
772018
Selective targeting of antiapoptotic BCL‐2 proteins in cancer
AC Timucin, H Basaga, O Kutuk
Medicinal research reviews 39 (1), 146-175, 2019
752019
Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells
ED Arisan, O Kutuk, T Tezil, C Bodur, D Telci, H Basaga
Breast cancer research and treatment 119, 271-281, 2010
742010
Apoptosis signalling by 4-hydroxynonenal: a role for JNK–c-Jun/AP-1 pathway
O Kutuk, H Basaga
Redox Report 12 (1-2), 30-34, 2007
732007
Aspirin Prevents Apoptosis and NF-κB Activation Induced by H2O2 in HeLa Cells
O Kutuk, H Basaga
Free radical research 37 (12), 1267-1276, 2003
642003
Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation
O Kutuk, ED Arisan, T Tezil, MC Shoshan, H Basaga
Carcinogenesis 30 (9), 1517-1527, 2009
622009
Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling
O Kutuk, G Poli, H Basaga
Toxicological sciences 90 (1), 120-132, 2006
602006
Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL
O Kutuk, SG Temel, S Tolunay, H Basaga
European journal of cancer 46 (13), 2494-2505, 2010
562010
Resveratrol protects against 4‐HNE induced oxidative stress and apoptosis in Swiss 3T3 fibroblasts
O Kutuk, M Adli, G Poli, H Basaga
Biofactors 20 (1), 1-10, 2004
522004
Migraine and associated comorbidities are three times more frequent in children with ADHD and their mothers
MO Kutuk, AE Tufan, G Guler, OO Yalin, E Altintas, HG Bag, D Uluduz, ...
Brain and Development 40 (10), 857-864, 2018
482018
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20